Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome

Clinical trial NCT02468193 · COMPLETED

Trial details

NCT number: NCT02468193
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cushing's Syndrome Ectopic Corticotropin Syndrome Adrenal Adenoma Adrenal Carcinoma AIMAH PPNAD

Start date: 2015-09-24
Primary completion: 2018-06-07
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.